Trademark: 90725302
Status Date
Monday, March 11, 2024
Filing Date
Thursday, May 20, 2021
Published for Opposition
Tuesday, July 19, 2022
5 Processed cellular bone matrix, namely, bone growth media containing stem cells for use in the treatment of musculoskeletal defects
Mar 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2024
Sou Extension 3 Granted
Mar 11, 2024
Sou Extension 3 Filed
Mar 11, 2024
Sou Teas Extension Received
Sep 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 5, 2023
Sou Extension 2 Granted
Sep 5, 2023
Sou Extension 2 Filed
Sep 5, 2023
Sou Teas Extension Received
Mar 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 3, 2023
Sou Extension 1 Granted
Mar 3, 2023
Sou Extension 1 Filed
Mar 3, 2023
Sou Teas Extension Received
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 14, 2022
Approved For Pub - Principal Register
Jun 13, 2022
Teas/Email Correspondence Entered
Jun 13, 2022
Correspondence Received In Law Office
Jun 13, 2022
Assigned To Lie
Jun 6, 2022
Teas Response To Office Action Received
Dec 11, 2021
Notification Of Non-Final Action E-Mailed
Dec 11, 2021
Non-Final Action E-Mailed
Dec 11, 2021
Non-Final Action Written
Dec 8, 2021
Assigned To Examiner
Jun 16, 2021
Teas Amendment Entered Before Attorney Assigned
Jun 16, 2021
Teas Voluntary Amendment Received
Aug 18, 2021
New Application Office Supplied Data Entered
May 24, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
